EMEA-000410-PIP01-08-M04
Key facts
| Invented name |
Rapiscan
|
| Active substance |
regadenoson
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0030/2019
|
| PIP number |
EMEA-000410-PIP01-08-M04
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Diagnosis of myocardial perfusion disturbances
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
GE Healthcare AS
Tel. +44 1494 543259 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|